The estimated Net Worth of Michael Boxer is at least $3.85 Milione dollars as of 2 February 2015. Mr. Boxer owns over 74,001 units of American Renal Associates stock worth over $3,642,088 and over the last 10 years he sold ARA stock worth over $0. In addition, he makes $211,858 as Independent Director at American Renal Associates.
Michael has made over 1 trades of the American Renal Associates stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 74,001 units of ARA stock worth $2,659,596 on 2 February 2015.
The largest trade he's ever made was exercising 74,001 units of American Renal Associates stock on 2 February 2015 worth over $2,659,596. On average, Michael trades about 12,334 units every 0 days since 2015. As of 2 February 2015 he still owns at least 101,338 units of American Renal Associates stock.
You can see the complete history of Mr. Boxer stock trades at the bottom of the page.
Michael E. Boxer serves as Independent Director of the Company. Mr. Boxer is President of The Enterprise Group Ltd., a healthcare advisory firm. Previously, he served as a senior advisor to Centerbridge Partners, L.P. from 2011 to 2018. Mr. Boxer serves on the board of directors of GI Scientific and Clever Care Health Plan, Inc. Mr. Boxer previously served as vice chairperson of the board of directors and as chairperson of the audit and compliance committees of Remedi SeniorCare Holding Corporation and served on the board of directors and was chairperson of the audit committee and compliance committees of Versant Health (formerly Superior Vision Corporation). He served as chairperson of the audit committee and as a board member of Genesis Healthcare, Inc. (formerly Skilled Healthcare Group, Inc.) from 2006 until 2015. Mr. Boxer served as the chief financial officer of HealthMarkets, Inc., a provider of health and life insurance products. Mr. Boxer was chief financial officer of Mariner Health Care, Inc., a skilled nursing facility and long-term acute care provider. Mr. Boxer served as chief financial officer of Allergan plc (formerly Watson Pharmaceuticals Inc.), an integrated specialty pharmaceutical company. Prior to that, Mr. Boxer was a healthcare investment banker at Furman Selz. Mr. Boxer received a B.B.A. in Finance from Colorado State University and an M.B.A. from the University of Chicago Booth School of Business.
As the Independent Director of American Renal Associates, the total compensation of Michael Boxer at American Renal Associates is $211,858. There are 5 executives at American Renal Associates getting paid more, with Don Williamson having the highest compensation of $1,772,140.
Michael Boxer is 58, he's been the Independent Director of American Renal Associates since 2010. There are 6 older and 5 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA, 01915.
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci e Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
American Renal Associates executives and other stock owners filed with the SEC include: